Professor of Surgery
University of Washington
Director of Limb Preservation Service
Harborview Medical Center
Seattle, Washington
Session Moderator
SESSION 28: NEW DEVELOPMENTS IN PROSTHETIC GRAFTS; STENT GRAFTS; PERCUTANEOUS ENDOVASCULAR BYPASSES; STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
Presenter
SESSION 28: NEW DEVELOPMENTS IN PROSTHETIC GRAFTS; STENT GRAFTS; PERCUTANEOUS ENDOVASCULAR BYPASSES; STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
Presenter
SESSION 29: FOOT PERFUSION EVALUATION METHODS; LOWER EXTREMITY RCTS: NEW CONCLUSIONS PRO AND CON
SESSION 28: NEW DEVELOPMENTS IN PROSTHETIC GRAFTS; STENT GRAFTS; PERCUTANEOUS ENDOVASCULAR BYPASSES; STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
Presenter
SESSION 28: NEW DEVELOPMENTS IN PROSTHETIC GRAFTS; STENT GRAFTS; PERCUTANEOUS ENDOVASCULAR BYPASSES; STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
For Primary Treatment Of CLTI What Is The Current Role And Proportion Of Patients Needing An Open Bypass In The Endovascular Era: What Percentage Of CLTI Patients Will Need An Open Bypass At Some Time In Their Course: What Percentage Of These Bypasses Will Have To Be Done With A PTFE Graft
2:25 PM - 2:30 PM
Presenter
SESSION 29: FOOT PERFUSION EVALUATION METHODS; LOWER EXTREMITY RCTS: NEW CONCLUSIONS PRO AND CON
Why CLTI Patients At Many Hospitals Could Not Be Included In The BEST-CLI Trial: Why This Weakens The Trial's Conclusions And Make Them Non-Applicable To Much Real-World Practice: What To Do About It
4:18 PM - 4:23 PM